半岛医疗“械三双子星”亮相 定义国产医美器械合规新标杆

Core Insights - The article highlights the launch of two new medical devices, Peninsula Super Cannon and Peninsula Counterclockwise, which have received NMPA Class III medical device registration and are now certified by FDA and CE, marking a significant step for the company in the global aesthetic medical market [1][2] Company Overview - Peninsula Medical, founded by Lei Xiaobing, aims to make advanced medical equipment affordable for thousands of hospitals in China that were previously dominated by international giants [1] - The company has expanded from Chongqing to Shanghai and finally established its base in Shenzhen, with products now sold in over 70 countries and regions, serving thousands of hospitals and aesthetic institutions [1] - The company boasts a research and development team of nearly 400 people, bridging clinical needs with engineering technology [1] Product Innovations - The Peninsula Super Cannon integrates a high-resolution intelligent ultrasound imaging system with treatment processes, introducing the SOP 3.0 precision treatment system, which allows for visual, quantifiable, and traceable treatment standards [2] - The Peninsula Counterclockwise, as the first domestic Class III radiofrequency microneedle device, addresses the industry pain point of balancing efficacy and comfort, utilizing multi-dimensional technological innovations [2] - Key features of the Peninsula Counterclockwise include layered treatment technology, mixed mode output, and a significant increase in energy delivery efficiency, which enhances patient comfort and reduces recovery time [2] Market Potential - According to third-party market research firm, Sullivan, China has become the fastest-growing market for photonic anti-aging treatments, with ultrasound and radiofrequency microneedles accounting for over 60% of the market, driving core growth in the industry [3] - The company expresses confidence in the future of Chinese aesthetic medical device enterprises and service institutions becoming global brands [3]